Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Using Multi-Scale Genetic, Neuroimaging and Clinical Data for Predicting Alzheimer's Disease and Reconstruction of Relevant Biological Mechanisms.

Scientific reports - 24 Jul 2018

Khanna Shashank, Domingo-Fernández Daniel, Iyappan Anandhi, Emon Mohammad Asif, Hofmann-Apitius Martin, Fröhlich Holger

Abstract excerpt

Alzheimer's Disease (AD) is among the most frequent neuro-degenerative diseases. Early diagnosis is essential for successful disease management and chance to attenuate symptoms by disease modifying drugs. In the past, a number of cerebrospinal fluid (CSF), plasma and neuro-imaging based biomarkers have been proposed. Still, in current clinical practice, AD diagnosis cannot be made until the patient shows clear...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adherens Junctions
Share to Autophagy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood-Brain Barrier

Share to Cognitive Dysfunction

Share to Early Diagnosis

Share to Machine Learning

Share to Models, Theoretical

Share to Neuroimaging

Source

Open in PubMed Open full text

Identifiers

PMID: 30042519
DOI: 10.1038/s41598-018-29433-3
PMCID: PMC6057884

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Using Multi-Scale Genetic, Neuroimaging and Clinical Data for Predicting Alzheimer's Disease and Reconstruction of Relevant Biological Mechanisms.PMID 30042519Read ↗

Multimodal Integration of Alzheimer's Plasma Biomarkers, MRI, and Genetic Risk for Individual Prediction of Cerebral Amyloid BurdenSemantic proximity Read ↗

Addition of Genetics to Quantitative MRI Facilitates Earlier Prediction of Dementia: A Non-invasive Alternative to Amyloid MeasuresSemantic proximity Read ↗

Predicting Alzheimer’s Trajectory: A Multi-PRS Machine Learning Approach for Early Diagnosis and Progression ForecastingSemantic proximity Read ↗

Identifying healthy individuals with Alzheimer neuroimaging phenotypes in the UK BiobankSemantic proximity Read ↗

A/T/N polygenic risk score for cognitive decline in old ageSemantic proximity Read ↗

Identifying healthy individuals with Alzheimer’s disease neuroimaging phenotypes in the UK BiobankSemantic proximity Read ↗

Endophenotype-based polygenic risk scores: Prediction of biomarker and clinical progression and dementiaSemantic proximity Read ↗

An Integrative Multimodal Model for Early Diagnosis of Dementia and Differential Diagnosis of Alzheimer’s Disease Using Neuroimaging, Polygenic Risk, and Cognitive AssessmentsSemantic proximity Read ↗

Integrative analyses of neuroimaging, clinical, and multi-omics data identified meaningful Alzheimer’s disease progression subtypesSemantic proximity Read ↗

Standardized Comparison of Clinical, Cognitive, Genetic, Neuroimaging, and Fluid Biomarkers for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer’s DiseaseSemantic proximity Read ↗

Integrating polygenic and transcriptional risk scores for detecting Alzheimer's disease.Semantic proximity Read ↗

Genetic risk in Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.